This is the authors' abstract. We don't add key points for this paper.
The unnatural labeled amino acid N‐acetyl‐D‐3‐(2‐naphthyl)‐[2,3‐3H] alanine having a specific activity of 43.7 Ci/mmol was obtained in 98.7% optical yield by asymmetric reduction of 2‐N‐acetylamino‐3‐(2‐naphthyl)acrylic acid with tritium gas in the presence of the chiral homogeneous catalyst (S,S)BPPM‐Rh+. This amino acid was used in a microscale solution phase synthesis of the labeled LHRH antagonist [Ac‐D‐(2,3‐3H) Nal1, D‐p‐Cl‐Phe2, D‐Trp3, D‐hArg (Et2)6, D‐Ala10] LHRH. The chiral synthesis of labeled amino acids as a strategy for the general synthesis of labeled peptides is discussed.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Parnes et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: